+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Interstitial Cystitis Drugs Market, by Drugs, by Route of Administration, by End User by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 142 Pages
  • August 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5417341
Interstitial Cystitis (IC) also called as painful bladder syndrome, is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. The pain ranges from mild discomfort to severe levels. The bladder expands until it is full and then gives signal to the brain that it is time to urinate, communicating through pelvic nerves. With IC, these signals get mixed up and then patient feels the need to urinate more often and with smaller volumes of urine than most people. The IC disease most often affects women and can has a long-lasting impact on the quality of life. Although there is no cure, medications, and other therapies may offer some relief.



There are two types of IC such as non-ulcerative IC, which is found in 90% of the population suffering from IC. It is characterized by pinpoint hemorrhages called glomerulations. Another type of IC is Ulcerative IC, which comprises of about 5-10% of the patient population. It is mainly characterized by Hunner’s ulcers and the patches that bleed on bladder walls. Hunner’s ulcers, also called “Hunner’s lesions” or “Hunner’s patches”, are a sub type of IC and are not ulcers in the usual sense. They are distinctive areas of inflammation on the bladder wall that characterize the “classic” form of IC, and it affects only about 5 to 10 percent of patients suffering from IC.

Market Dynamics


The high prevalence of interstitial cystitis is driving the global interstitial cystitis drugs market. Patients suffering from interstitial cystitis experience symptoms such as lower urinary tract issues and bladder pain. Women are highly affected by this condition. According to Patnaik et al., 2017, prevalence estimates suggest that 45 per 100,000 females and 8 per 100,000 men are diagnosed with IC in North America.

Key features of the study:

  • This report provides in-depth analysis of the global interstitial cystitis drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global interstitial cystitis drugs market based on the following parameters – Company Highlights, Product Portfolio, Key Highlights, Financial Performance, and Market Strategies.
  • Key companies covered as a part of this study include Bayer AG, Eli Lilly and Co., Johnson & Johnson, Mylan NV, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Seikagaku Corp., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global interstitial cystitis drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interstitial cystitis drugs market

Detailed Segmentation:


Global Interstitial Cystitis Drugs market, By Drugs:

  • Pentosan Polysulfate Sodium
  • Dimethyl Sulfoxide
  • Others

Global Interstitial Cystitis Drugs market, By Route of Administration:

  • Oral Therapy
  • Intravesical Therapy

Global Interstitial Cystitis Drugs market, By End User:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Interstitial Cystitis Drugs Market, By Region:

  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country
  • South Africa
  • Central Africa
  • North Africa

Company Profiles

  • Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Eli Lilly and Co.
  • Johnson & Johnson
  • Mylan NV
  • Novartis AG
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Seikagaku Corp.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
“*” marked represents similar segmentation in other categories in the respective section.
Frequently Asked Questions about the Interstitial Cystitis Drugs Market

What is the estimated value of the Interstitial Cystitis Drugs Market?

The Interstitial Cystitis Drugs Market was estimated to be valued at $206.6 Million in 2021.

What is the growth rate of the Interstitial Cystitis Drugs Market?

The growth rate of the Interstitial Cystitis Drugs Market is 6.6%, with an estimated value of $323.4 Million by 2028.

What is the forecasted size of the Interstitial Cystitis Drugs Market?

The Interstitial Cystitis Drugs Market is estimated to be worth $323.4 Million by 2028.

Who are the key companies in the Interstitial Cystitis Drugs Market?

Key companies in the Interstitial Cystitis Drugs Market include Bayer AG, Eli Lilly and Co., Johnson & Johnson, Mylan NV, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Seikagaku Corp. and Teva Pharmaceutical Industries Ltd..

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Drugs
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By End User
  • Market Snapshot, By Region
  • Market Opportunity Map

3. Global Interstitial Cystitis Drugs Market Insights
  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Product Launches
  • Acquisition
  • Epidemiology
  • Recent Product Launches
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • Porters Five Force Model

4. Global Interstitial Cystitis Drugs Market- COVID-19 Impact Analysis
  • Economic Impact
  • COVID-19 Epidemiology
  • Demand and Supply Analysis

5. Global Interstitial Cystitis Drugs Market, By Drugs, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Pentosan Polysulfate Sodium
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Dimethyl Sulfoxide
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

6. Global Interstitial Cystitis Drugs Market, By Route of Administration, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Oral Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Intravesical Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

7. Global Interstitial Cystitis Drugs Market, By End User, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million
  • Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

8. Global Interstitial Cystitis Drugs Market, By Region, 2017 - 2028 (US$ Million)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Region at Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2017-2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • U.S.
  • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2017-2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2017-2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2017-2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2017-2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drugs, 2017-2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028, (US$ Mn)
  • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Snapshot
Company Profiles
  • Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Eli Lilly and Co.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Mylan NV
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Perrigo Co. Plc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Seikagaku Corp.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section
  • Research Methodology
  • About us

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bayer AG
  • Eli Lilly and Co.
  • Johnson & Johnson
  • Mylan NV
  • Novartis AG
  • Perrigo Co. Plc
  • Pfizer Inc.
  • Seikagaku Corp.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.